Scientific principles guiding risk-based cervical cancer screening in resource-limited settings

Human papillomavirus (HPV) causes 660,000 cases and 350,000 deaths globally despite effective vaccination, screening, and treatment options; few are feasible to implement in resource-limited settings where the burden of cervical cancer is high. A single-dose, multivalent HPV vaccination of adolescent females could prevent the majority of cancers, making it the undisputed priority. However, vaccination programs leave a decades-long time lag between prophylaxis of HPV infection and cancer prevention in later adulthood. Screening for and treatment of precancer in mid-adulthood could save additional millions of lives. There are pertinent scientific facts concerning HPV natural history and cervical carcinogenesis so firmly established that they are beyond reasonable dispute. With the realization that scientific certainty demands extraordinary evidence that will always be further refined, a group of cervical cancer prevention specialists with experience in resource-limited settings met intending to posit such a set of fundamental scientific principles.

Authors

Institutions

Publication Details

Journal
Infectious Agents and Cancer
Published
2026-11-17
DOI
https://doi.org/10.1186/s13027-026-00825-9
Primary Topic
Cervical Cancer and HPV Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Scientific principles guiding risk-based cervical cancer screening in resource-limited settings

Jerome Leslie Belinson, Teresa Norris, Karen Yeates, Nicole G. Campos et al.
Infectious Agents and Cancer
Cervical Cancer and HPV Research
article

Scientific principles guiding risk-based cervical cancer screening in resource-limited settings

Jerome Leslie Belinson, Teresa Norris, Karen Yeates, Nicole G. Campos, Purnima Madhivanan, RACHEL J. MASCH, Jayashree Kalpathy–Cramer, Didem Egemen, Brian Befano, Federica Inturrisi, Ruchi S. Pathak, Jennifer Boyd-Morin, MARK H. SCHIFFMAN, Miriam Cremer, Suzanne Belinson, Ignacio Priéto, Ana Karoline da Costa Ribeiro, Vijayalakshmi Ramshankar, Christopher R. Clark, Silvia de Sanjosé, Ruifang Wu, Kanan Desai, Ana Cecilia Rodriguez, Devanshi Somaya, Lisa Lewis, Steve QuXInfeng, Imran Morhason Bello
article en

Abstract

Human papillomavirus (HPV) causes 660,000 cases and 350,000 deaths globally despite effective vaccination, screening, and treatment options; few are feasible to implement in resource-limited settings where the burden of cervical cancer is high. A single-dose, multivalent HPV vaccination of adolescent females could prevent the majority of cancers, making it the undisputed priority. However, vaccination programs leave a decades-long time lag between prophylaxis of HPV infection and cancer prevention in later adulthood. Screening for and treatment of precancer in mid-adulthood could save additional millions of lives. There are pertinent scientific facts concerning HPV natural history and cervical carcinogenesis so firmly established that they are beyond reasonable dispute. With the realization that scientific certainty demands extraordinary evidence that will always be further refined, a group of cervical cancer prevention specialists with experience in resource-limited settings met intending to posit such a set of fundamental scientific principles.

Infectious Agents and Cancer
National Institutes of Health (US), Harvard University (US), Universidade de Brasília (BR), University of Ibadan (NG), Universidad Rey Juan Carlos (ES), University of Washington (US), Queen's University (CA), University College Hospital, Ibadan (NG), Cancer Institute (WIA) (IN), University of Surrey (GB), Cleveland Clinic Lerner College of Medicine (US), Donald & Barbara Zucker School of Medicine at Hofstra/Northwell (US), Information Management Services (US), Peking University Shenzhen Hospital (CN), Hospital Universitário de Brasília (BR), National Cancer Institute (US), Barcelona Institute for Global Health (ES), Public Health Research Institute Of India (IN), Médecins Sans Frontières (FR), University of Arizona Cancer Center (US), University of Colorado Anschutz Medical Campus (US), Concordia University (CA)
Cervical Cancer and HPV Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon